Cartesian Therapeutics (RNAC) Interest Expenses (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Interest Expenses of $1.2 million for Q1 2026, up 268.77% year-over-year from $317000.0 in Q1 2025, and up 3.0% quarter-over-quarter from $1.1 million in Q4 2025.
Cartesian Therapeutics (RNAC) Interest Expenses (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Interest Expenses for 12 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 268.77% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $3.6 million (down 97.27% YoY), while the FY2025 annual figure was $296.9 million, up 19.79% from the prior year.
- Interest Expenses climbed to $1.2 million in Q1 2026 per RNAC's latest filing, from $1.1 million in the prior quarter.
- Across five years, Interest Expenses topped out at $130.5 million in Q4 2023 and bottomed at $317000.0 in Q1 2025.
- Historically, Interest Expenses has averaged $13.2 million across 5 years, with a median of $1.2 million in 2026.
- Annual changes were most pronounced in 2023 — Interest Expenses surged 7874.39% — and 2024, when it tumbled 99.23%.
- Cartesian Therapeutics' Interest Expenses stood at $1.6 million in 2022, then soared by 7874.39% to $130.5 million in 2023, then sank by 99.23% to $1.0 million in 2024, then advanced by 12.27% to $1.1 million in 2025, then advanced by 3.0% to $1.2 million in 2026.
- Business Quant data shows RNAC's Interest Expenses at $1.2 million in Q1 2026, $1.1 million in Q4 2025, and $5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - | 13.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.63 Mn |
| Jun 30, 2026 | 13.63 Mn |
| Mar 31, 2026 | 1.17 Mn |
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 5.09 Mn |
| Sep 30, 2025 | 5.09 Mn |
| Jun 30, 2025 | 17.02 Mn |
| Jun 30, 2025 | 17.02 Mn |
| Mar 31, 2025 | 317,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Dec 31, 2024 | 1.01 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 15.21 Mn |
| Sep 30, 2024 | 15.21 Mn |
| Jun 30, 2024 | 33.08 Mn |
| Jun 30, 2024 | 33.08 Mn |
| Mar 31, 2024 | 12.69 Mn |
| Mar 31, 2024 | 12.69 Mn |